Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAP256V2LS and VRC07-523LS in HIV Negative Women
NCT07810062Phase 2Completed
- Sponsor
- Center for Infectious Disease Research in Zambia
- Start
- Aug 2023
- Primary completion
- Jun 2024
- Countries
- 1
01
Overview
A Phase 2 trial of CAP256V2LS, VRC07-523LS in human immunodeficiency virus infection (HIV), sponsored by Center for Infectious Disease Research in Zambia. Started Aug 2023; status: completed.
02
Drugs
CAP256V2LSVRC07-523LS
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT07810062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07810062.